Zander M - Search Results

1

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

Zander M, Madsbad S, Madsen JL, Holst JJ. Zander M, et al. Lancet. 2002 Mar 9;359(9309):824-30. doi: 10.1016/S0140-6736(02)07952-7. Lancet. 2002. PMID: 11897280 Clinical Trial.

2

Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.

Zander M, Taskiran M, Toft-Nielsen MB, Madsbad S, Holst JJ. Zander M, et al. Diabetes Care. 2001 Apr;24(4):720-5. doi: 10.2337/diacare.24.4.720. Diabetes Care. 2001. PMID: 11315837 Clinical Trial.

3

Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.

Hermansen K, Vaaler S, Madsbad S, Dalgaard M, Zander M, Begtrup K, Soendergaard K. Hermansen K, et al. Among authors: zander m. Metabolism. 2002 Jul;51(7):896-900. doi: 10.1053/meta.2002.33358. Metabolism. 2002. PMID: 12077738 Clinical Trial.

4

Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

Zander M, Christiansen A, Madsbad S, Holst JJ. Zander M, et al. Diabetes Care. 2004 Aug;27(8):1910-4. doi: 10.2337/diacare.27.8.1910. Diabetes Care. 2004. PMID: 15277416 Clinical Trial.

5

The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.

Zander M, Madsbad S, Deacon CF, Holst JJ. Zander M, et al. Diabetologia. 2006 Feb;49(2):369-74. doi: 10.1007/s00125-005-0098-y. Epub 2005 Dec 30. Diabetologia. 2006. PMID: 16385384 Clinical Trial.

6

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.

Højberg PV, Zander M, Vilsbøll T, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S. Højberg PV, et al. Among authors: zander m. Diabetologia. 2008 Apr;51(4):632-40. doi: 10.1007/s00125-008-0943-x. Epub 2008 Feb 22. Diabetologia. 2008. PMID: 18292985

7

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.

Højberg PV, Vilsbøll T, Zander M, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S. Højberg PV, et al. Among authors: zander m. Diabet Med. 2008 Nov;25(11):1268-75. doi: 10.1111/j.1464-5491.2008.02579.x. Diabet Med. 2008. PMID: 19046215

8

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.

Faber R, Zander M, Pena A, Michelsen MM, Mygind ND, Prescott E. Faber R, et al. Among authors: zander m. Cardiovasc Diabetol. 2015 Apr 22;14:41. doi: 10.1186/s12933-015-0206-3. Cardiovasc Diabetol. 2015. PMID: 25896352 Free PMC article. Clinical Trial.

9

Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Nilsson M, Jensen N, Gejl M, Bergmann ML, Storgaard H, Zander M, Miskowiak K, Rungby J. Nilsson M, et al. Among authors: zander m. Diabetologia. 2019 Oct;62(10):1948-1958. doi: 10.1007/s00125-019-4964-4. Epub 2019 Jul 31. Diabetologia. 2019. PMID: 31367958 Clinical Trial.

10

[The prevalence of type 2-diabetes in ethnic minorities].

Zander M, Hansen CR, Koefoed BG, Perrild H. Zander M, et al. Ugeskr Laeger. 2012 Sep 10;174(37):2154-8. Ugeskr Laeger. 2012. PMID: 22971296 Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results